This 82-page report presents extensive data and commentary on the flow of funds to Alzheimers and dementia research in the USA, Europe, Japan, and China, Australia, Canada and Australia – with particular emphasis on the USA. The study tracks the flow of grants and contracts to universities and private sector entities and profiles the efforts of numerous leading American universities including but not limited to Columbia University, Harvard University, the University of Southern California, Washington University, Boston University and many others. In addition, it examines the role of non-USA universities and research bodies including the Shanghai Institute of Materia Medica, University College London, the French National Research Agency, the University of Toronto and many others.